Remineralization of enamel subsurface lesions by casein phosphopeptide-stabilized calcium phosphate solutions.
Casein phosphopeptides (CPP) stabilize amorphous calcium phosphate (ACP), localize ACP in dental plaque, and are anticariogenic in animal and in situ human caries model. In this vitro study, CPP-stabilized calcium phosphate solutions were shown to remineralize subsurface lesions in human third-molar enamel. Solutions were used to examine the effect of CPP-calcium phosphate concentration on remineralization. Other solutions were used to examine the effect of increasing pH, which decreased the concentrations of free calcium and phosphate ions and increased the level of CPP-bound ACP. Although most of the remineralizing solutions were supersaturated with respect to the amorphous and crystalline calcium phosphate phases, the solutions were stabilized by the CPP such that spontaneous precipitation of calcium phosphate did not occur. After a ten-day remineralization period, enamel lesions were sectioned, subjected to microradiography, and the mineral content determined by microdensitometry. All solutions deposited mineral into the bodies of the lesions, with the 1.0% CPP-calcium phosphate (pH 7.0) solution replacing 63.9 +/- 20.1% of mineral lost at an averaged rate of 3.9 +/- 0.8 x 10(-8) mol hydroxyapatite/m2/s. The remineralizing capacity was greater for the solutions with the higher levels of CPP-stabilized free calcium and phosphate ions. Remineralization was not significantly correlated with either the CPP-bound ACP of the degrees of saturation for hydroxyapatite, octacalcium phosphate, or ACP. However, remineralization was significantly correlated with the degree of saturation for dicalcium phosphate dihydrate (CaHPO4.2H2O), but his was attributed to the significant correlation of remineralization with the activity gradients from the solution into the lesion of some calcium phosphate ions and ion pairs, in particular the neutral ion pair CaHPO4(0). The CPP, by stabilizing calcium phosphate in solution, maintain high-concentration gradients of calcium and phosphate ions and ion pairs into the subsurface lesion and thus effect high rates of enamel remineralization.
Reynolds
E C
EC
Biochemistry and Molecular Biology Unit, School of Dental Science, University of Melbourne, Australia.
D002118:Calcium / Q000737:chemistry; D002130:Calcium Phosphates / Q000737:chemistry / Q000627:therapeutic use*; D002327:Cariostatic Agents / Q000627:therapeutic use; D002364:Caseins / Q000737:chemistry / Q000627:therapeutic use*; D011232:Chemical Precipitation; D003461:Crystallography; D003743:Dental Enamel / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D017886:Durapatite / Q000737:chemistry; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008852:Microradiography; D008855:Microscopy, Electron, Scanning; D008903:Minerals / Q000032:analysis; D008964:Molar, Third; D010710:Phosphates / Q000737:chemistry; D010748:Phosphopeptides / Q000737:chemistry / Q000627:therapeutic use*; D010783:Photometry; D012995:Solubility; D012996:Solutions; D017001:Tooth Demineralization / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D014089:Tooth Remineralization / Q000379:methods*
D002130:Calcium Phosphates; D002327:Cariostatic Agents; D002364:Caseins; D008903:Minerals; D010710:Phosphates; D010748:Phosphopeptides; D012996:Solutions; C485828:alpha-tricalcium phosphate; C519480:amorphous calcium phosphate; C485830:tetracalcium phosphate; C022045:octacalcium phosphate; C485838:calcium phosphate, monobasic, anhydrous; D017886:Durapatite; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous; D002118:Calcium